157 related articles for article (PubMed ID: 19346476)
1. Transience of MHC Class I-restricted antigen presentation after influenza A virus infection.
Mintern JD; Bedoui S; Davey GM; Moffat JM; Doherty PC; Turner SJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6724-9. PubMed ID: 19346476
[TBL] [Abstract][Full Text] [Related]
2. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
[TBL] [Abstract][Full Text] [Related]
3. Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.
Denton AE; Wesselingh R; Gras S; Guillonneau C; Olson MR; Mintern JD; Zeng W; Jackson DC; Rossjohn J; Hodgkin PD; Doherty PC; Turner SJ
J Immunol; 2011 Dec; 187(11):5733-44. PubMed ID: 22039305
[TBL] [Abstract][Full Text] [Related]
4. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.
Ballesteros-Tato A; León B; Lee BO; Lund FE; Randall TD
Immunity; 2014 Jul; 41(1):127-40. PubMed ID: 25035957
[TBL] [Abstract][Full Text] [Related]
5. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109
[TBL] [Abstract][Full Text] [Related]
6. The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia.
Topham DJ; Castrucci MR; Wingo FS; Belz GT; Doherty PC
J Immunol; 2001 Dec; 167(12):6983-90. PubMed ID: 11739518
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
Crowe SR; Miller SC; Shenyo RM; Woodland DL
J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
[TBL] [Abstract][Full Text] [Related]
8. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
9. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting.
Jenkins MR; Webby R; Doherty PC; Turner SJ
J Immunol; 2006 Sep; 177(5):2917-25. PubMed ID: 16920927
[TBL] [Abstract][Full Text] [Related]
10. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.
Belz GT; Xie W; Altman JD; Doherty PC
J Virol; 2000 Apr; 74(8):3486-93. PubMed ID: 10729122
[TBL] [Abstract][Full Text] [Related]
11. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
[TBL] [Abstract][Full Text] [Related]
12. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
[TBL] [Abstract][Full Text] [Related]
13. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection.
Kim TS; Hufford MM; Sun J; Fu YX; Braciale TJ
J Exp Med; 2010 Jun; 207(6):1161-72. PubMed ID: 20513748
[TBL] [Abstract][Full Text] [Related]
14. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.
Barbet G; Nair-Gupta P; Schotsaert M; Yeung ST; Moretti J; Seyffer F; Metreveli G; Gardner T; Choi A; Tortorella D; Tampé R; Khanna KM; García-Sastre A; Blander JM
Nat Immunol; 2021 Apr; 22(4):497-509. PubMed ID: 33790474
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
16. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
[TBL] [Abstract][Full Text] [Related]
17. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
[TBL] [Abstract][Full Text] [Related]
18. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
19. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
Mitsui H; Inozume T; Kitamura R; Shibagaki N; Shimada S
J Invest Dermatol; 2006 Aug; 126(8):1804-12. PubMed ID: 16645583
[TBL] [Abstract][Full Text] [Related]
20. Memory regulatory T cells home to the lung and control influenza A virus infection.
Lu C; Zanker D; Lock P; Jiang X; Deng J; Duan M; Liu C; Faou P; Hickey MJ; Chen W
Immunol Cell Biol; 2019 Oct; 97(9):774-786. PubMed ID: 31116465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
